跳至主要内容
临床试验/ITMCTR2200006687
ITMCTR2200006687尚未招募未知

The effects of Mawangdui therapy on the pulmonary function, physical fitness levels and quality of life in stable Chronic Obstructive Pulmonary Disease (COPD) patients

Pan Xiaoyan0 个研究点开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
50 至 70(—)
性别
All

入选标准

  • 1. Age range 50-70 years old.
  • 2. COPD patient admitted to Changde First Hospital of Traditional Chinese Medicine.
  • 3. COPD patients in mild to moderate remission classification (stage I or II). At the same time, the patients are in a stable stage, namely, the symptoms such as cough and shortness of breath are well managed, and pulmonary decline is minimised. Medical doctors will select patients who meet the inclusion criteria.

排除标准

  • 1. Patients with severe liver and kidney damage.
  • 2. Recent use of immunosuppressants.
  • 3. Not suitable for physical exercise (assessed via Physical Activity Readiness Medical Examination, PARmed-X+) .
  • 4. Patients needing ventilation or oxygen therapy.
  • 5. Patients with poor compliance (<80% attendance) and unable to finish the 6-month course of exercise intervention treatment.

研究者

发起方
Pan Xiaoyan

相似试验